Forced expiratory volume in  second (FEV)/forced vital capacity (FVC) > % by pulmonary function test (PFT), unless due to large mediastinal mass from Hodgkin lymphoma (HL)
Forced expiratory volume in  second (FEV) and forced vital capacity (FVC) >= % of predicted; or in pediatric patients, if unable to perform pulmonary function tests due to young age, oxygen saturation > % on room air
Participants with unilateral pleural effusion are eligible if they fulfill both of the following: (a) New York Heart Association (NYHA) Class ; (b) Global initiative for obstructive lung disease (GOLD) test level  (forced expiratory volume in  second [FEV]/ forced vital capacity [FVC] less than [<] . and FEV greater than or equal to [>=]  percent [%] predicted after inhaled bronchodilator)
Forced expiratory volume in  second (FEV)/forced vital capacity (FVC) >= % predicted
Pulmonary function tests (spirometry) demonstrating forced expiratory value (FEV)  greater than % predicted or forced vital capacity (FVC) greater than % of predicted.
Subjects must have had recent pulmonary function test (PFT) measured for at least  months prior to study enrollment that show:\r\n* A decrease in % forced vital capacity (FVC) and/or % forced expiratory volume in  second (FEV) ? % at screening compared with pre-transplant baseline\r\n* Lack of bronchodilator response on PFT testing < % change and <  ml change in FEV and/or FVC
If pulmonary function tests (PFTs) are performed, the forced expiratory volume  (FEV)/forced vital capacity (FVC) must be greater than %
Patients with moderate to severe lung disease including: \r\n* Patients requiring oxygen (O) supplementation\r\n* Patients unable to walk  feet without stopping to rest\r\n** Obstructive lung disease as defined by pre-transplant forced expiratory volume in one second (FEV) =< % of predicted\r\n** Restrictive lung disease as defined by pre-transplant forced vital capacity (FVC) < % of predicted
Patients with pulmonary function test abnormalities as evidenced by a forced expiratory volume in  second to forced vital capacity ratio measurement (FEV/FVC) < % of predicted for normality will be excluded
Pulmonary function tests (forced expiratory volume in  second [FEV] > % or forced vital capacity [FVC] > % of predicted) within  month of lymphodepletion
Forced expiratory volume in  second (FEV) >= % predicted (corrected for hemoglobin); if unable to perform pulmonary function tests, the oxygen (O) saturation > % on room air
The following pulmonary function tests (PFT) values in baseline:\r\n* Forced expiratory volume in one second (FEV) > % predicted\r\n* FEV/forced vital capacity (FVC) > %\r\n* Residual volume (RV)/total lung capacity (TLV) >= %
Adequate pulmonary reserve defined as adequate airflow defined by a measured forced expiratory volume (FEV) not less than % of the predicted value and adequate pulmonary reserve as evidenced by a FEV/forced vital capacity (FVC) ratio of % or greater
Pulmonary function tests (forced expiratory volume in one second [FEV] > % or forced vital capacity [FVC] > % of predicted) within  months of lymphodepletion (Turnstile II)
Forced expiratory volume in one second (FEV) and forced vital capacity (FVC) >= % of predicted; or in pediatric patients, if unable to perform pulmonary function tests due to young age, oxygen saturation > % on room air
Forced expiratory volume in one second (FEV)/forced vital capacity (FVC) >= % by pulmonary function test; for children who are uncooperative, no evidence of dyspnea at rest, or exercise intolerance, and must have a pulse oximetry > % in room air
Forced expiratory volume in one second (FEV) and forced vital capacity (FVC) < % predicted
Pulmonary function tests (forced expiratory volume in one second [FEV] > % or forced vital capacity [FVC] > % of predicted) within  months of lymphodepletion (Turnstile II - Chemotherapy/Cell Infusion - Inclusion Criteria)
Forced expiratory volume in  second (FEV) and forced vital capacity (FVC) >= % of predicted (patients >=  years old)
Normal lung function; patients who have extensive pulmonary metastases or any chronic pulmonary disease history must have pulmonary function testing demonstrating forced expiratory volume in  second (FEV) and forced vital capacity (FVC) > % of predicted values
Forced expiratory volume >= . L or >= % of predicted with or without bronchodilators by pulmonary function testing
Pulmonary function tests (forced expiratory volume in one second [FEV] > % or forced vital capacity [FVC] > % of predicted are required) within  months of lymphodepletion in those who have a history of pulmonary disease that necessitates the use of supplemental oxygen, or is associated with dyspnea on walking one block or less, or requires inhaler therapy more than once per week
Adequate lung function; forced vital capacity (FVC) and forced expiratory volume in  second (FEV) ? % of predicted value as measured by spirometry; and oxygen saturation ? % on room air
Forced expiratory volume in one second (FEV) AND forced vital capacity (FVC) > % predicted
Forced expiratory volume in  second (FEV) and forced vital capacity (FVC) >= % of predicted; or if unable to perform pulmonary function tests due to young age, oxygen saturation > % on room air
Decrease in FEV of >= % from the baseline (FEV/forced vital capacity [FVC] ratio < .); NOTE: baseline may be defined as either pre- or post-transplant, as assessed by the treating physician
Forced expiratory volume in  second (FEV) and forced vital capacity (FVC) >= % of predicted (for patients who have not received thoracic or mantle irradiation; for patients who have received thoracic or mantle irradiation, FEV and FVC >= % of predicted
Forced expiratory volume in one second (FEV) and forced vital capacity (FVC) > % predicted by pulmonary function test; for children who are unable to do pulmonary function tests (PFTs), no evidence of dyspnea at rest and no exercise intolerance should be documented; note: the pulmonary function test must be performed within  weeks prior to enrollment
Subjects with evidence of underlying obstructive pulmonary disease prior to transplant (clinical history of asthma or baseline forced expiratory volume in  second [FEV] < % predicted with FEV/forced vital capacity [FVC] < %)
Forced expiratory volume in one second (FEV) and forced vital capacity (FVC) >= % of predicted; or if unable to perform pulmonary function tests due to young age, oxygen saturation > % on room air
Severe obstructive lung disease (forced expiratory volume in  second [FEV]/forced vital capacity [FVC] < % post bronchodilator and forced expiratory volume in  second < % predicted)
Forced vital capacity (FVC) or forced expiratory volume of the lung in  second (FEV) >= % predicted
Chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease (GOLD) II or greater (defined as forced expiratory volume in  second [FEV]/ forced vital capacity [FVC] < % and FEV % predicted < %)
Patients must have adequate pulmonary function: forced expiratory volume in one second (FEV) and forced vital capacity (FVC) at least % predicted value by spirometry
At least one of the following:\r\n* Mild or worse sputum cytologic atypia\r\n* Endobronchial dysplasia (score >= ) on a previous bronchoscopy.\r\n* At least mild airflow limitation on pulmonary function testing (forced expiratory volume in one second [FEV]/forced vital capacity [FVC] < % actual)
COPD, defined as forced expiratory volume in  second (FEV)/forced vital capacity (FVC) < % and FEV% predicted < %